Malaria journal, 2019-10, Vol.18 (1), p.339-339, Article 339
2019
Details
- Autor(en) / Beteiligte
- Titel
- Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
- Ist Teil von
- Malaria journal, 2019-10, Vol.18 (1), p.339-339, Article 339
- Ort / Verlag
- England: BioMed Central Ltd
- Erscheinungsjahr
- 2019
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- Managing multidrug resistant malaria can be problematic if currently available artemisinin-containing anti-malarial combination treatments are not used appropriately. Here, I debate that the best way to manage multidrug resistant malaria is to make best use of existing treatments and to develop new classes of anti-malarial drugs and not to make 'triple combination therapies' when there is already resistance to one or more proposed components.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1475-2875eISSN: 1475-2875DOI: 10.1186/s12936-019-2976-7Titel-ID: cdi_doaj_primary_oai_doaj_org_article_67e4387191e5428894934e483a7c8fc7
- Format
- –
- Schlagworte
- Antimalarials, Antimalarials - chemistry, Antimalarials - economics, Artemisinin, Artemisinins - economics, Artemisinins - therapeutic use, Debate, Drug Combinations, Drug Resistance, Humans, Malaria, Malaria - drug therapy, Malaria - prevention & control, Public Health - legislation & jurisprudence, Public Health - standards, Toxicity